Suchen Sie nach Informationen zu Unternehmenszentrale Von Biogen Idec? Folgen Sie den Links unten, um alle Informationen zu finden, die Sie benötigen, und mehr.
We aspire to transform patients’ lives and Biogen by making personalized & digital medicine in neuroscience a reality. Powered by data science and digital technologies, we drive solutions to advance research, clinical care, and patient empowerment. We believe that now, more than ever, biology and technology should go hand-in-hand to better ...
https://www.denodo.com/de/kunde/biogen-idec
Biogen is a global biotechnology company, founded in 1978, with over $4B in revenue. Biogen Idec is a global leader in the discovery, development, manufacturing and commercialization of innovative therapies such as multiple sclerosis (MS), lymphoma and rheumatoid arthritis.
https://investors.biogen.com/news-releases/news-release-details/biogen-idec-becomes-biogen
March 23, 2015 • Corporate. New Corporate Identity and Brand Reflect Company’s Heritage and Commitment to Patients and Science. CAMBRIDGE, Mass.-- ( BUSINESS WIRE )--Effective today, Biogen Idec is known simply as Biogen (NASDAQ: BIIB). The company has introduced a new corporate identity and logo that reflect both its evolution and focus on ...
https://www.company-histories.com/Biogen-Idec-Inc-Company-History.html
Biogen Idec Inc., formed through the 2003 merger of Biogen Inc. and IDEC Pharmaceuticals Corporation (Idec), is a biotechnology company focused on developing treatments for cancer and autoimmune and inflammatory diseases. The company's portfolio of approved drugs includes Rituxan and Zevalin, both of which treat B-cell non-Hodgkin's lymphoma.
https://www.fda.gov/about-fda/ora-foia-electronic-reading-room/biogen-idec-inc
Biogen Idec Inc., RTP, NC, 483 Issued 8/2/2013; Content current as of: 12/06/2013. Topic(s) Freedom of Information (FOI) ORA FOIA Electronic Reading Room Footer Links. FDA Archive ...
https://rocketreach.co/biogen-idec-profile_b5c616abf42e0c4c
Biogen Idec Information. Through cutting-edge science and medicine, Biogen discovers, develops and delivers innovative therapies worldwide for people living with serious neurological and neurodegenerative diseases. Founded in 1978, Biogen is a pioneer in biotechnology and today the Company has the leading portfolio of medicines to treat ...
https://www.pharmaceutical-technology.com/projects/biogen/
In March 2003 Biogen Idec began construction of its first production facility to be located outside of the USA. The plant, situated 25 miles north of Copenhagen on a 60 acre site at Hillerød, is in an area known as ‘Medicon Valley’ because of its attractiveness to pharmaceutical companies. The facility is intended to supply the European ...
http://media.biogen.com/news-releases/news-release-details/biogen-idec-and-samsung-bioepis-announce-agreement-market-anti
About Biogen Idec. Through cutting-edge science and medicine, Biogen Idec discovers, develops and delivers to patients worldwide innovative therapies for the treatment of neurodegenerative diseases, hemophilia and autoimmune disorders. Founded in 1978, Biogen Idec is the world’s oldest independent biotechnology company.
https://ispe.org/facility-year-awards/company/biogen-idec
2010 FOYA Category Winners. Biogen Idec Operational Excellence The over arching mission of Biogen Idec’s Technology Map program was to enhance its world-class bulk biologics production facility in Research Triangle Park, North Carolina to support...
https://www.faz.net/aktuell/wirtschaft/unternehmen/idec-und-biogen-ein-neuer-biotech-riese-entsteht-1104221.html
Die Konsolidierung in der Biotechnologiebranche kommt einen weiteren Schritt voran. Idec Pharmaceuticals übernimmt Aktien im Wert von 6,65 Milliarden Dollar seines Wettbewerbers Biogen.
Wir hoffen, dass Sie über die obigen Links alle notwendigen Informationen zu Unternehmenszentrale Von Biogen Idec gefunden haben.
